Zinc Protoporphyrin IX Stimulates Tumor Immunity by Disrupting the Immunosuppressive Enzyme Indoleamine 2,3-Dioxygenase

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-10-0185
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Indoleamine 2,3-Dioxygenase 1 (IDO1)

Science-Business eXchange
2012English

Inhibition of Experimental Asthma by Indoleamine 2,3-Dioxygenase

Journal of Clinical Investigation
Medicine
2004English

Induction of Pulmonary Indoleamine 2,3-Dioxygenase by Interferon.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1981English

Cardiac and Gastrointestinal Liabilities Caused by Deficiency in the Immune Modulatory Enzyme Indoleamine 2,3-Dioxygenase

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2011English

Amino Acid Deprivation Links BLIMP-1 to the Immunomodulatory Enzyme Indoleamine 2,3-Dioxygenase

Journal of Immunology
AllergyImmunology
2009English

Mechanisms of Vesicular Stomatitis Virus Inactivation by Protoporphyrin IX, Zinc-Protoporphyrin IX, and Mesoporphyrin IX

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2017English

Immunotherapeutic Suppression of Indoleamine 2,3-Dioxygenase and Tumor Growth With Ethyl Pyruvate

Cancer Research
Cancer ResearchOncology
2010English

Indole Peroxygenase Activity of Indoleamine 2,3-Dioxygenase

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2012English

Induction of Indoleamine 2,3-Dioxygenase by Interferon- In Human Islets

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy